A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)

Clinical Trial

Study Details

Enrollment

159

Interventions

Description

Tablets

Name

Mitapivat Matched Placebo

Type

Drug

Description

Tablets

Name

Mitapivat

Type

Drug

Phase

Phase 3

Status

RECRUITING

Study ID #

NCT07656415

Study Type

Interventional

Summary

The primary objective of this study is to determine the effect of mitapivat versus placebo on the need for transfusions in subjects with SCD.

Study Overview

Conditions

Sickle Cell Disease

Contacts and Locations

Locations

Facility

Indiana Hemophilia & Thrombosis Center
Indianapolis, Indiana 46260
United States

GeoPoint

39.76838, -86.15804

Status

Recruiting

Facility

The Cancer and Hematology Centers (CHC)
Grand Rapids, Michigan 49503
United States

GeoPoint

42.96336, -85.66809

Status

Recruiting

Facility

Southern Specialty Clinic
Flowood, Mississippi 39232
United States

GeoPoint

32.30959, -90.13898

Status

Recruiting

Facility

Icahn School of Medicine at Mount Sinai
New York, New York 10029
United States

GeoPoint

40.71427, -74.00597

Status

Recruiting

Facility

University of Texas Health Science Center at Houston
Houston, Texas 77030
United States

GeoPoint

29.76328, -95.36327

Status

Recruiting